Complete remission of refractory small cell carcinoma of the pancreas with cisplatin and etoposide.

作者信息

Morant R, Bruckner H W

机构信息

Neoplastic Diseases and Medicine, Mount Sinai Medical Center, New York, New York.

出版信息

Cancer. 1989 Nov 15;64(10):2007-9. doi: 10.1002/1097-0142(19891115)64:10<2007::aid-cncr2820641006>3.0.co;2-7.

A case of unusually large widespread metastatic small cell carcinoma of the pancreas is presented. The patient remains in complete remission 50 months after the diagnosis and initiation of combination chemotherapy using a schedule consisting of etoposide (150 mg/m2) intravenously (IV) on days 1 to 3 and cisplatin (100 mg) IV on day 2. Initial chemotherapy with streptozotocin, 5-fluorouracil, and methotrexate, doxorubicin, cyclophosphamide, and lomustine (MACC) had been unsuccessful.